EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time

Yaye D Ndiaye, Wesley Wong, Julie Thwing, Stephen F Schaffner, Katelyn Vendrely Brenneman, Abdoulaye Tine, Mamadou A Diallo, Awa B Deme, Mouhamad Sy, Amy K Bei, Alphonse B Thiaw, Rachel Daniels und 31 weitere

Malaria Journal · 09.07.2024 · 23 (1)

DOI: 10.1186/s12936-024-05024-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaria Journal, online erschienen am 09.07.2024. Verfasst von Yaye D Ndiaye und 42 weiteren Autor:innen. Beteiligte Einrichtung: International Research Training Center On Genomics and Health Surveillance (CIGASS), Cheikh Anta Diop University, 16477, Dakar, Senegal. Hauptthemen laut MEDLINE: Plasmodium falciparum, Drug Resistance, Antimalarials, Mutation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill and Melinda Gates Foundation, NIH/ICEMR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug resistance in Plasmodium falciparum is a major threat to malaria control efforts. Pathogen genomic surveillance could be invaluable for monitoring current and emerging parasite drug resistance.

Methods

Data from two decades (2000–2020) of continuous molecular surveillance of P. falciparum parasites from Senegal were retrospectively examined to assess historical changes in malaria drug resistance mutations. Several known drug resistance markers and their surrounding haplotypes were profiled using a combination of single nucleotide polymorphism (SNP) molecular surveillance and whole genome sequence based population genomics.

Results

This dataset was used to track temporal changes in drug resistance markers whose timing correspond to historically significant events such as the withdrawal of chloroquine (CQ) and the introduction of sulfadoxine-pyrimethamine (SP) in 2003. Changes in the mutation frequency at Pfcrt K76T and Pfdhps A437G coinciding with the 2014 introduction of seasonal malaria chemoprevention (SMC) in Senegal were observed. In 2014, the frequency of Pfcrt K76T increased while the frequency of Pfdhps A437G declined. Haplotype-based analyses of Pfcrt K76T showed that this rapid increase was due to a recent selective sweep that started after 2014.

Discussion

(Conclusion) The rapid increase in Pfcrt K76T is troubling and could be a sign of emerging amodiaquine (AQ) resistance in Senegal. Emerging AQ resistance may threaten the future clinical efficacy of artesunate-amodiaquine (ASAQ) and AQ-dependent SMC chemoprevention. These results highlight the potential of molecular surveillance for detecting rapid changes in parasite populations and stress the need to monitor the effectiveness of AQ as a partner drug for artemisinin-based combination therapy (ACT) and for chemoprevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumDrug ResistanceAntimalarialsMutationSenegalRetrospective StudiesHumansMalaria, FalciparumPolymorphism, Single NucleotideProtozoan ProteinsHaplotypesMembrane Transport Proteins

Substanzen

AntimalarialsProtozoan ProteinsMembrane Transport Proteins

Autor:innen und Institutionen

  • International Research Training Center On Genomics and Health Surveillance (CIGASS), Cheikh Anta Diop University, 16477, Dakar, Senegal.
  • Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA, 02115, USA.
  • Malaria Branch, Division of Parasitic Diseases and Malaria, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Broad Institute of MIT and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.
  • Yale School of Public Health, 60 College St, New Haven, CT, 06510, USA.
  • Department of Biochemistry and Functional Genomics, Sherbrooke University, 2500 Bd de L'Universite, Sherbrooke, QC, J1K 2R1, Canada.

Förderung

  • NIAID NIH HHS
  • Bill and Melinda Gates Foundation
  • NIH/ICEMR

Zitieren

APA

Ndiaye, Y. D., Wong, W., Thwing, J., Schaffner, S. F., Brenneman, K. V., Tine, A., Diallo, M. A., Deme, A. B., Sy, M., Bei, A. K., Thiaw, A. B., Daniels, R., Ndiaye, T., Gaye, A., Ndiaye, I. M., Toure, M., Gadiaga, N., Sene, A., Sow, D., …, & Ndiaye, D. (2024). Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time. Malaria Journal, 23(1). https://doi.org/10.1186/s12936-024-05024-8

Vancouver

Ndiaye YD, Wong W, Thwing J, Schaffner SF, Brenneman KV, Tine A, et al. Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time. Malaria Journal. 2024;23(1). doi:10.1186/s12936-024-05024-8

BibTeX
@article{Ndiaye2024,
  author = {Ndiaye, Yaye D and Wong, Wesley and Thwing, Julie and Schaffner, Stephen F and Brenneman, Katelyn Vendrely and Tine, Abdoulaye and Diallo, Mamadou A and Deme, Awa B and Sy, Mouhamad and Bei, Amy K and Thiaw, Alphonse B and Daniels, Rachel and Ndiaye, Tolla and Gaye, Amy and Ndiaye, Ibrahima M and Toure, Mariama and Gadiaga, Nogaye and Sene, Aita and Sow, Djiby and Garba, Mamane N and Yade, Mamadou S and Dieye, Baba and Diongue, Khadim and Zoumarou, Daba and Ndiaye, Aliou and Gomis, Jules F and Fall, Fatou B and Ndiop, Medoune and Diallo, Ibrahima and Sene, Doudou and Macinnis, Bronwyn and Seck, Mame C and Ndiaye, Mouhamadou and Ngom, Bassirou and Diedhiou, Younouss and Mbaye, Amadou M and Ndiaye, Lamine and Sy, Ngayo and Badiane, Aida S and Hartl, Daniel L and Wirth, Dyann F and Volkman, Sarah K and Ndiaye, Daouda},
  title = {Two decades of molecular surveillance in Senegal reveal rapid changes in known drug resistance mutations over time},
  journal = {Malaria Journal},
  year = {2024},
  volume = {23},
  number = {1},
  doi = {10.1186/s12936-024-05024-8}
}
Kostenlos starten →